Eugia Pharma Specialities Limited Ertapenem Export Data — India (DGFT 2022–2026)

Name: Eugia Pharma Specialities Limited Ertapenem Export Records India — #1 Exporter, 537 Shipments, $26.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ertapenem

India Pharmaceutical Trade Intelligence

$109.0M54 Suppliers46 CountriesHS 30042099

ExportsIndia → UNITED STATES54.9%India → MALTA15.7%

ImportsUNITED STATES → India$34.5K AUSTRALIA → India$9.3K

#1 Supplier: EUGIA PHARMA #1 Buyer: EUGIA US

Eugia Pharma Specialities Limited — Ertapenem Exporter #1 | $26.9M Trade Value | TransData Nexus | TransData Nexus

Eugia Pharma Specialities Limited — Ertapenem Exporter Profile

Indian Pharmaceutical Exporter · #1 for Ertapenem · $26.9M export value · DGFT Verified

Eugia Pharma Specialities Limited is the #1 Indian exporter of Ertapenem with $26.9M in export value and 537 verified shipments. Eugia Pharma Specialities Limited holds a 24.6% market share in Ertapenem exports across 11 countries. The company exports 49 pharmaceutical products worth $170.1M across 14 therapeutic categories.

Eugia Pharma Specialities Limited — Ertapenem Export Profile: Buyers & Destinations

Eugia Pharma Specialities Limited Ertapenem export treemap — buyers and destination countries | TransData Nexus

Where Does Eugia Pharma Specialities Limited Export Ertapenem?

Country	Value	Shipments	Share
UNITED STATES	$15.0M	301	56.1%
MALTA	$6.3M	126	23.4%
BRAZIL	$1.6M	32	6.0%
CANADA	$1.6M	31	5.8%

Who Are the Top Buyers of Ertapenem from Eugia Pharma Specialities Limited?

Buyer	Country	Value	Orders
EUGIA US LLC,	UNITED STATES	$5.6M	112
EUGIA US LLC	UNITED STATES	$5.5M	111
AUROMEDICS PHARMA, LLC,	UNITED STATES	$2.5M	50
EUGIA PHARMA (MALTA) LTD,	MALTA	$2.0M	41
EUGIA US LLC.	UNITED STATES	$1.3M	25
APL SWIFT SERVICES (MALTA) LTD.	MALTA	$1.3M	25
EUGIA PHARMA INDUSTRIA FARMACEUTICA	BRAZIL	$1.1M	21
EUGIA PHARMA MALTA LIMITED	MALTA	$800.0K	16
AURO PHARMA INC	CANADA	$650.0K	13
EUGIA PHARMA (MALTA) LIMITED	MALTA	$650.0K	13

Eugia Pharma Specialities Limited supplies Ertapenem to 47 buyers globally. The largest buyer is EUGIA US LLC, (UNITED STATES), followed by EUGIA US LLC (UNITED STATES) and AUROMEDICS PHARMA, LLC, (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ertapenem Formulations Does Eugia Pharma Specialities Limited Export?

Product Description / Formulation	Value	Shipments
ERTAPENEM FOR INJECTION 1 G/VIAL(Ertapen	$3.3M	66
ERTAPENEM FOR INJECTION 1 G/VIALErtapen	$1.1M	22
ERTAPENEM FOR INJECTION 1 G/VIAL,(ERTAPE	$1.1M	21
ERTAPENEM FOR INJECTION 1 G/VIAL (ERTAPE	$800.0K	16
ERTAPENEM FOR INJECTION 1 G/VIAL (IVERZA	$350.0K	7
ERTAPENEM FOR INJECTION 1 G/VIAL (Ertape	$350.0K	7
ERTAPENEM FOR INJECTION 1G/VIAL(Ertapene	$300.0K	6
ERTAPENEM FOR INJECTION 1 G/VIAL(ERTAPEN	$300.0K	6
ERTAPENEM FOR INJECTION 1G/VIAL(ERTAPENE	$300.0K	6
ERTAPENEM FOR INJECTION 1 G/VIALERTAPEN	$250.0K	5

Eugia Pharma Specialities Limited exports 349 distinct Ertapenem formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ERTAPENEM FOR INJECTION 1 G/VIAL(Ertapen with 66 shipments worth $3.3M.

How Does Eugia Pharma Specialities Limited Compare to Nearest Ertapenem Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	EUGIA PHARMA SPECIALITIES LIMITED ★	$26.9M	537	11	$50.0K
4	DR.REDDY'S LABORATORIES LTD	$1.8M	35	2	$50.0K
3	GLAND PHARMA LIMITED	$1.4M	29	4	$50.0K

Eugia Pharma Specialities Limited ranks #1 among 54 Indian Ertapenem exporters. Average shipment value of $50.0K compared to the market average of $649.6K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and GLAND PHARMA LIMITED.

Which Indian Ports Ship Ertapenem Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	248	31.8%
DELHI AIR	185	23.7%
Delhi Air	71	9.1%
HYDERABAD ACC (INHYD4)	52	6.7%
HYDERABAD AIR	33	4.2%
PETRAPOLE	23	2.9%
SAHAR AIR	21	2.7%
Dadri CGML	19	2.4%

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Ertapenem Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Eugia. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical hurdles are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management. (pharmaceuticalcommerce.com)

Conversely, U.S.-China trade tensions have opened avenues for Indian exporters. With the U.S. seeking to diversify its supply chains away from China, Indian pharmaceutical companies have the opportunity to capture a larger share of the U.S. market. Eugia's recent FDA approvals and product launches position it well to capitalize on this shift.

However, the imposition of new tariffs by the U.S. administration in August 2025, affecting over 60 countries including India, poses a significant challenge. These tariffs, reaching up to 39%, could impact nearly 55% of India's exports to the U.S., including pharmaceuticals. The increased cost burden may erode profit margins and affect competitiveness in the U.S. market. (apnews.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Indian exporters must ensure stringent adherence to serialization and traceability standards to maintain access to the EU market. Eugia's commitment to quality and regulatory compliance will be pivotal in navigating these regulatory landscapes.

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the USFDA intensifying inspections and compliance requirements. Eugia's experience with the USFDA's warning letter for its Unit-III facility underscores the importance of robust quality management systems. Addressing these regulatory observations is crucial for maintaining market access and reputation.

Indian pharmaceutical companies, including Eugia, are investing in upgrading manufacturing practices to meet international standards. This proactive approach is essential to mitigate risks associated with non-compliance and to sustain growth in regulated markets.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ertapenem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Eugia Pharma Specialities Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 537 individual customs records matching Eugia Pharma Specialities Limited exporting Ertapenem, covering 349 formulations to 11 countries via 47 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 46+ countries, 137+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ertapenem

Ertapenem

Eugia Pharma Specialities Limited — Ertapenem Exporter Profile

Eugia Pharma Specialities Limited — Ertapenem Export Profile: Buyers & Destinations

Where Does Eugia Pharma Specialities Limited Export Ertapenem?

Who Are the Top Buyers of Ertapenem from Eugia Pharma Specialities Limited?

What Is India's Total Ertapenem Export Value and How Much Does Eugia Pharma Specialities Limited Contribute?

What Is the Average Shipment Value for Eugia Pharma Specialities Limited's Ertapenem Exports?

How Does Eugia Pharma Specialities Limited Compare to Other Indian Ertapenem Exporters?

What Ertapenem Formulations Does Eugia Pharma Specialities Limited Export?

Regulatory Requirements: Exporting Ertapenem to Key Markets

United States — FDA

Brazil — ANVISA

How Does Eugia Pharma Specialities Limited Compare to Nearest Ertapenem Exporters?

Which Indian Ports Ship Ertapenem Exports?

What Other Advanced Antibiotics Products Does Eugia Pharma Specialities Limited Export?

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Ertapenem Exports

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

About Eugia Pharma Specialities Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ertapenem Export Data from Eugia Pharma Specialities Limited

Ertapenem Stats

Company Overview

Top Products by Eugia Pharma Specialities Limited

Related Analysis

Need Detailed Export Data?

Data Source